- Home
- SGHT vs GLDG Comparison
SGHT vs GLDG Comparison
Compare SGHT & GLDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGHT
- GLDG
- Stock Information
- Founded
- SGHT 2011
- GLDG 2009
- Country
- SGHT United States
- GLDG Canada
- Employees
- SGHT N/A
- GLDG N/A
- Industry
- SGHT Medical Specialities
- GLDG Precious Metals
- Sector
- SGHT Health Care
- GLDG Basic Materials
- Exchange
- SGHT Nasdaq
- GLDG Nasdaq
- Market Cap
- SGHT 179.7M
- GLDG 161.2M
- IPO Year
- SGHT 2021
- GLDG N/A
- Fundamental
- Price
- SGHT $4.12
- GLDG $0.81
- Analyst Decision
- SGHT Buy
- GLDG Strong Buy
- Analyst Count
- SGHT 8
- GLDG 1
- Target Price
- SGHT $4.16
- GLDG $3.25
- AVG Volume (30 Days)
- SGHT 120.0K
- GLDG 550.1K
- Earning Date
- SGHT 08-07-2025
- GLDG 07-14-2025
- Dividend Yield
- SGHT N/A
- GLDG N/A
- EPS Growth
- SGHT N/A
- GLDG N/A
- EPS
- SGHT N/A
- GLDG N/A
- Revenue
- SGHT $76,303,000.00
- GLDG N/A
- Revenue This Year
- SGHT N/A
- GLDG N/A
- Revenue Next Year
- SGHT $11.22
- GLDG N/A
- P/E Ratio
- SGHT N/A
- GLDG N/A
- Revenue Growth
- SGHT N/A
- GLDG N/A
- 52 Week Low
- SGHT $2.03
- GLDG $0.71
- 52 Week High
- SGHT $7.05
- GLDG $1.06
- Technical
- Relative Strength Index (RSI)
- SGHT 60.97
- GLDG 56.97
- Support Level
- SGHT $3.11
- GLDG $0.78
- Resistance Level
- SGHT $4.27
- GLDG $0.84
- Average True Range (ATR)
- SGHT 0.23
- GLDG 0.03
- MACD
- SGHT 0.09
- GLDG 0.00
- Stochastic Oscillator
- SGHT 87.07
- GLDG 59.50
About SGHT Sight Sciences Inc.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
About GLDG GoldMining Inc.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia; Crucero project, located in Peru; Sao Jorge, Batistao, located in Brazil; Yellowknife Gold Project, located in the Northwest Territories, Canada; and various other projects such as Cachoeira, Yarumalito, Whistler, Surubim, Montes Aureos and Trinta, Rea across different locations. The company has two operating segments, with U.S. GoldMining being one distinct operating segment and all other subsidiaries, or Others, being the second operating segment.